AGE Structures and their Biomedical Significance
AGE Structures and their Biomedical Significance
批准号:
10044305
负责人:
HORIUCHI Seikoh
金额:
$8.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A).
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000
中文摘要
蛋白质与葡萄糖的长期孵育通过席夫碱和Amadori产物导致晚期糖基化终产物(AGE)的形成。从三个方面研究了体内AGE的生物医学意义:(1)体内主要AGE结构的鉴定;(2)AGE受体在组织中的定位;(3)AGE受体的结构和功能分析。(1)体内主要AGE结构的鉴定:甲基乙二醛是糖酵解和多元醇途径的产物,通过裂解3-磷酸甘油醛与蛋白质反应生成AGE,如N,ε-(羧乙基)赖氨酸。特别是,美拉德反应中席夫碱的裂解也产生了甲基乙二醛,进而促进了AGE的进一步形成。(Ii)AGE在组织中的定位:在肺纤维化患者的肺巨噬细胞中发现了主要的AGE结构之一N-ε-(羧甲基)赖氨酸(CML)的积累家族性肌萎缩侧索硬化症患者有更多的SIS和神经元,强烈提示AGE可能参与了这些疾病的发病过程。(Iii)AGE受体的结构和功能分析:为了评估肝内皮细胞(LEC)中AGE受体的表达,我们还确定了在LEC中高表达的清道夫受体B类分子CD-36和SR-BI是否作为AGE受体。CD36高表达的CHO细胞内吞AGE蛋白,细胞内AGE蛋白降解,提示CD36可识别原位生成的AGE配体,这可能参与糖尿病大血管并发症的发病机制。通过使用SR-BI过表达的CHO细胞(SR-BI-CHO),我们清楚地表明SR-BI也作为AGE受体参与内吞AGE蛋白的过程。此外,AGE-蛋白不仅能有效地抑制SR-BI介导的从高密度脂蛋白颗粒中选择性摄取CE,而且还能有效地抑制高密度脂蛋白介导的胆固醇从SR-BI-CHO细胞中流出,表明AGE-配体在体内高密度脂蛋白介导的胆固醇反向转运中起着重要作用。较少
英文摘要
Long-term incubation of proteins with glucose leads, through the Schiff base and Amadori product, to the formation of advanced glycation end products (AGE). The biomedical significance of AGE in vivo were studied from three lines of aspects ; (i) identification of major AGE-structures in vivo, (ii) and their localization in tissues and (iii) structural and functional analyses of AGE-receptors.(i) Identification of major AGE-structures in vivo : Methylglyoxal, which was generated from glycolysis and polyol pathways through the cleavage of gleceraldehyde-3-phosphate, reacted with protein to form the AGE such as N^ε-(carboxyethyl)lysine (CEL). Especially, methylglyoxal was also generated from the cleavage of Schiff base of the Maillard reaction, followed by contribution to further AGE formation.(ii) Localization of AGE in tissues : Accumulation of N^ε-(carboxymethyl)lysine (CML), one of the major AGE structures, has been identified in pulmonary macrophages in patients with pulmonary fibro … More sis and neuron in patient with familial amyotrophic lateral sclerosis, strongly suggesting that AGE may involve in the pathogenesis of these disease processes.(iii) Structural and functional analysis of AGE receptor : To evaluate the AGE-receptor expressed in liver endothelial cells (LEC), we also determined whether scavenger receptor class B such as CD-36 and SR-BI, highly expressed in LEC, serve as an AGE receptor. CD-36-overexpressed CHO cells showed endocytic uptake and subsequent intracellular degradation of AGE-proteins, suggesting that AGE-ligands generated in situ are recognized by CD36, which might contribute to the pathogenesis of diabetic macrovascular complications. By using SR-BI-overexpressed CHO cells (SR-BI-CHO), we clearly showed that SR-BI also serves as an AGE receptor involved in endocytic uptake of AGE-proteins. Furthermore, AGE-protein effectively inhibited not only SR-BI-mediated selective uptake of CE from HDL particles, but also HDL-mediated cholesterol efflux from SR-BI-CHO cells, indicating that AGE-ligands play a significant role in the HDL-mediated reverse cholesterol transport in vivo. Less
期刊论文(141)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., Makino, H.: "Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy : aminoguanidine ameliorates the overexpression of tumor necrosis factor-alph
Sugimoto, H.、Shikata, K.、Wada, J.、Horiuchi, S.、Makino, H.:“糖尿病肾病发展中的高级糖基化终末产物-细胞因子-一氧化氮序列途径:氨基胍改善肿瘤的过度表达
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Abiko, A., Eto, M., Makino, I., Araki, N., and Horiuchi, S.: "Increased levels of advanced glycosylation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay"Metabolism.. 49. 567-573 (2000)
Abiko, A.、Eto, M.、Makino, I.、Araki, N. 和 Horiuchi, S.:“通过免疫化学测定测定自发性糖尿病中国仓鼠的肾脏和肝脏中高级糖基化终产物的水平增加”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Honda K et al.: "Accumualtion of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration"Nephrol. Dial. Transplant. 14. 1541-1549 (1999)
Honda K 等人:“低超滤连续流动腹膜透析患者腹膜血管系统中晚期糖基化终产物的积累”Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 128 条
Roles of CD36 and SR-BI as novel AGE-receptors
-
批准号:13470228
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2001
-
负责人:HORIUCHI Seikoh
-
依托单位:
Role of AGE Receptors in Diabetic Complications
-
批准号:11557081
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:HORIUCHI Seikoh
-
依托单位:
Biological clearance system for advanced glycation end products (AGE) -Insulin signal regulates endocytic uptake of AGE-proteins
-
批准号:09470225
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:1997
-
负责人:HORIUCHI Seikoh
-
依托单位:
Molecular Biology of Acyl-coenzyme A : cholesterol Acyltransferase
-
批准号:08044304
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.46万
-
财政年份:1996
-
负责人:HORIUCHI Seikoh
-
依托单位:
Detemination of The Main Advanced Glycation End Product of The Maillard Reaction and Its Significance as A Biochemical Marker for Diabetic Complications
-
批准号:07557076
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$9.28万
-
财政年份:1995
-
负责人:HORIUCHI Seikoh
-
依托单位:
Structure and Function of Receptors for Advanced Glycation End Products of the Maillard Reaction
-
批准号:06454170
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.61万
-
财政年份:1994
-
负责人:HORIUCHI Seikoh
-
依托单位:
Non-enzymatic glycosylation of proteins in biological sytem and its physiological significance in aging process.
-
批准号:62570136
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1987
-
负责人:HORIUCHI Seikoh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: